glp-1 heart attack Frontiers How GLP-1 Medications Reduce Heart

doi: 10.3389/fendo.2019.00155 96 ChristouGAKatsikiNBlundellJFruhbeckGKiortsisDN

Calorie restriction alone doesn't fix the signalling problem

There is no benefit to weight loss during pregnancy and it may cause harm to the unborn baby

Research Diets, Inc

LY2189265, a long-acting glucagon-like peptide-1 analogue, showed a dose-dependent effect on insulin secretion in healthy subjects

"Our nomination provides numerous examples of these risks, including unknown impurities, peptide-related impurities, incorrect strengths, and even instances where no semaglutide was present in the product at all," Novo Nordisk spokesperson Jamie Bennet wrote in an email to NPR